Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability ...
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in ...
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email